Phytocannabinoids in Triple Negative Breast Cancer Treatment: Current Knowledge and Future Insights
Anticancer Research · 2023-03 · 43 (3) · 993-1000
DOI: 10.21873/anticanres.16243 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Anticancer Research, online erschienen am 28.02.2023. Verfasst von Sabrina Bimonte und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Anesthesia and Pain Medicine Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples, Italy; s.bimonte@istitutotumori.na.it. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Cannabidiol. Die Arbeit wurde bisher 14-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Anesthesia and Pain Medicine Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples, Italy; s.bimonte@istitutotumori.na.it.
- SSD Sperimentazione Animale, Istituto Nazionale per lo Studio e la Cura dei Tumori "Fondazione G. Pascale", IRCCS, Naples, Italy.
- Division of Anesthesia and Pain Medicine Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples, Italy.
Zitieren
APA
Bimonte, S., Palma, G., Cascella, M., & Cuomo, A. (2023). Phytocannabinoids in Triple Negative Breast Cancer Treatment: Current Knowledge and Future Insights. Anticancer Research, 43(3), 993-1000. https://doi.org/10.21873/anticanres.16243
Vancouver
Bimonte S, Palma G, Cascella M, Cuomo A. Phytocannabinoids in Triple Negative Breast Cancer Treatment: Current Knowledge and Future Insights. Anticancer Research. 2023;43(3):993-1000. doi:10.21873/anticanres.16243
BibTeX
@article{Bimonte2023,
author = {Bimonte, Sabrina and Palma, Giuseppe and Cascella, Marco and Cuomo, Arturo},
title = {Phytocannabinoids in Triple Negative Breast Cancer Treatment: Current Knowledge and Future Insights},
journal = {Anticancer Research},
year = {2023},
volume = {43},
number = {3},
pages = {993--1000},
doi = {10.21873/anticanres.16243}
}
EUVIMED